Status:
COMPLETED
De-implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-risk Adenomas
Lead Sponsor:
Kaiser Permanente
Conditions:
Polyp of Colon
Eligibility:
All Genders
54-70 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the effectiveness of three standard of care outreach approaches (i.e., mailed letter, secure message, and telephone call) on patient adoption of the new 10-year...
Eligibility Criteria
Inclusion
- Kaiser Permanente Northern California (KPNC) membership\>12 months
- Primary medical center is either KP San Rafael, KP San Francisco, KP San Leandro, or KP Walnut Creek
- 54-70 years of age at time of 5-year surveillance colonoscopy interval
- A baseline colonoscopy with a finding of 1-2 small tubular adenomas and are due for their 5-year surveillance procedure in 2022
- Average risk for CRC
- A valid mailing address, kp.org account (i.e., KPNC's secure messaging portal), and telephone number at time of study enrollment.
Exclusion
- More than 12 months of membership prior to index colonoscopy, and indications that would make an individual above average risk for CRC, such as: adenoma with advanced histology on colonoscopy, adenoma \>10 mm on colonoscopy, family history of CRC, prior history of colonoscopy, prior history of adenomas or colon polyp diagnoses, history of IBD, history of hereditary polyposis syndrome, 3 or more adenomas, adenoma 10 mm in size or greater, adenoma with advanced histology, and any sessile serrated polyp or traditional serrated adenoma
Key Trial Info
Start Date :
May 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 8 2023
Estimated Enrollment :
604 Patients enrolled
Trial Details
Trial ID
NCT05389397
Start Date
May 12 2022
End Date
September 8 2023
Last Update
September 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente San Francisco Medical Center
San Francisco, California, United States, 94115